New NHS treatment could transform lives of thousands of children with brain tumours
by The Independent
The Independent— Combination of dabrafenib and trametinib can now be used for patients aged one and over
The Independent—New targeted treatment approved for children with brain cancer. The drugs improve children’s response rate to treatment and survival time without the disease getting worse.
The Scottish Sun—First new brain tumour drug for 20 years could give children an extra 18 months with family. CHILDREN with deadly brain tumours could get an 18-month survival boost with the first new NHS drug for almost 20 years. The medicines watchdog has approved the gene-targeting drug combination of d
The Guardian—‘Kinder’ treatment for childhood brain cancer to be offered by NHS in England. Dabrafenib with trametinib can halt growth of some tumours for more than three times as long as standard chemotherapy, study showsThe NHS is to offer children with brain tumours in England a groundbreaking new targeted drug therapy to tackle the disease – a development charities are hailing as the biggest breakthrough in decades.Gliomas are the most common type of brain cancer in children but experts say the standard treatment of chemotherapy can be brutal and gruelling, and also carries the...